Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Apotex' Aleve PM Rival Could Have 180-Day Exclusivity As A CGT

Sep 03 2019

• By Malcolm Spicer

Apotex exterior

Related Content

US FDA’s First Competitive Generic Therapy Approval Comes With A Twist

Aug 10 2018

<em>Aleve PM</em> Enters Nighttime Pain-Relief Market After 160-Count Label Approved

Sep 22 2014

GAO Report Casts Shade On Sunscreen Ingredients' Chances With FDA

Nov 21 2017

Monograph Reform Legislation In Play As FDA, OTC Industry Get Real On Changes

May 23 2019

Related Companies

Apotex Inc.

Bayer AG

Amneal Pharmaceuticals, Inc.

Perrigo Company PLC

Additional Topics

United States Canada Regulation OTC Drugs FDA Consumer BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window